DAVEHIGH SIGNALFINANCIAL10-K

DAVE demonstrated substantially higher revenue growth while dramatically strengthening its balance sheet position through increased stockholders' equity and cash reserves.

The company's financial transformation suggests successful execution of its neobanking strategy, with revenue growing meaningfully while maintaining disciplined cost management as evidenced by the modest liability increase. The near-doubling of stockholders' equity combined with strengthened cash position indicates improved financial stability and potential for sustained growth in the competitive fintech space.

Comparing 2026-03-02 vs 2025-03-04View on EDGAR →
FINANCIAL ANALYSIS

DAVE's financial profile strengthened considerably across key metrics, with revenue growing substantially while total assets expanded significantly to $487.4M. The balance sheet improvements were particularly notable, as stockholders' equity nearly doubled and cash reserves grew meaningfully to $80.5M, while liabilities increased only modestly. This combination of robust top-line growth and enhanced financial positioning signals a company gaining traction in the neobanking market while building a more resilient capital structure.

FINANCIAL STATEMENT CHANGES
Stockholders Equity
Balance Sheet
+92.6%
$183.1M$352.7M

Equity base grew 92.6% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Total Assets
Balance Sheet
+62.8%
$299.3M$487.4M

Asset base grew 62.8% — expansion through organic growth, acquisitions, or capital deployment.

Cash & Equivalents
Balance Sheet
+62%
$49.7M$80.5M

Cash position surged 62% — strong cash generation or capital raise providing significant financial cushion.

Revenue
P&L
+59.7%
$347.1M$554.2M

Strong top-line growth of 59.7% — accelerating demand or successful expansion into new markets.

Current Assets
Balance Sheet
+54.7%
$282.3M$436.7M

Current assets grew 54.7% — improving short-term liquidity or inventory/receivables build.

Capital Expenditure
Cash Flow
+21%
$262K$317K

Capex increased 21% — ongoing investment in capacity or infrastructure for future growth.

Total Liabilities
Balance Sheet
+15.9%
$116.2M$134.7M

Liabilities increased 15.9% — monitor debt-to-equity ratio and interest coverage.

LANGUAGE CHANGES
NEW — 2026-03-02
PRIOR — 2025-03-04
ADDED
As of February 17, 2026, there were 12,569,569 and 12,245,516 shares of Class A common stock, $0.0001 par value, issued and outstanding, respectively.
As of February 17, 2026, there were 1,314,082 shares of Class V common stock, $0.0001 par value, issued and outstanding.
Each warrant was originally exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share.
In connection with the 1-for-32 reverse stock split effected on January 5, 2023, the exercise terms of the warrants were proportionately adjusted pursuant to the anti-dilution provisions of the warrant agreement, such that 32 warrants are now exercisable for one share of Class A Common Stock at an adjusted exercise price of $368.00 per share.
The number of warrants outstanding was not affected by the reverse stock split.
+7 more — sign up free →
REMOVED
As of February 20, 2025, there were 11,580,041 shares of Class A common stock, $0.0001 par value and 1,514,082 shares of Class V common stock, $0.0001 par value, issued and outstanding.
Company Overview Dave was launched in 2017 to provide a faster, more transparent, and lower-cost alternative to traditional financial institutions, particularly for those living paycheck to paycheck.
Through our mobile-first platform, we deliver innovative financial products designed to help underserved consumers manage their money more effectively.
We have engineered a purpose-driven platform designed to deliver on our mission, making a significant impact across the stakeholder groups we serve.
Since our inception, more than 16 million Members have signed up for the Dave app, with over 12 million having used at least one of our products.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →